SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-122434
Filing Date
2023-04-27
Accepted
2023-04-27 16:43:18
Documents
15
Period of Report
2023-04-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d500394d8k.htm   iXBRL 8-K 30604
2 EX-10.1 d500394dex101.htm EX-10.1 324523
3 EX-99.1 d500394dex991.htm EX-99.1 13176
7 GRAPHIC g500394g0427051003319.jpg GRAPHIC 4274
  Complete submission text file 0001193125-23-122434.txt   557761

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA enta-20230425.xsd EX-101.SCH 2848
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE enta-20230425_lab.xml EX-101.LAB 17236
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enta-20230425_pre.xml EX-101.PRE 10811
9 EXTRACTED XBRL INSTANCE DOCUMENT d500394d8k_htm.xml XML 3279
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35839 | Film No.: 23857900
SIC: 2834 Pharmaceutical Preparations